Ghrelin: A Stomach Hormone Impacts Mood, Behavior, Sickness and Parkinson's Disease.

Background: In our last blog, we discussed the relationship of environmental toxicants on TLR receptor activation and reviewed how LPS endotoxin is a ligand for the TLR4 receptor. In addition, we mentioned how endotoxin and TLR plays a role in immune related disorders including RA and neurodegenerative disease and that it is also implicated as a causal factor in a number of environmental diseases including chronic fatigue syndrome. Generally, TLR signaling may contribute to a number of  conditions considered environmental diseases through the interaction and modulation of inflammatory cytokines. Lastly, in the past we noted that oxidation of phospholipids occurs at the site of inflammation and provides a small level of protection against TLR signaling but not against against Il-1 and Tnf-a. The level of TLR protection is dependant on the balance between the types of involved phospholipids. Smoking and ozone increase one type, PGCP that prevents the protection by Nrf2 against this type of stress.

A recent study has provided evidence that a stomach hormone called ghrelin may prevent or slow the onset of Parkinson's disease. As we noted above, TLR signaling has been implicated in the development of the condition and this study helps to provide insight in to a possible as to why. As Wipedia explains, ghrelin is a hormone that is produced in the stomach and the pancreas to produce the feeling of hunger. It also is produced in the part of the brain called the hypothalamus and stimulates secretion of growth hormone in the pituitary gland. Importantly, it is a hormone needed for learning and cognitive functioning necessary for adaptive behaviors and stimulates the endothelial form of nitric oxide. Ghrelin levels fluctuate during a 24-hour period and consequently this hormone has important implications in alterations of sleep duration, stress-induced depression, obesity and anorexia nervosa. Researchers are also focusing their attention on how alterations of ghrelin production may influence the development of addictive behaviors.

In 2006, Wang demonstrated that LPS endotoxin can inhibit the production of ghrelin and that exogenous application of ghrelin may normalize endotoxic-induced digestive dysfunction. There are findings of different studies that show that LPS endotoxin can raise or lower this hormones secretion and it is highly likely, other immune interactions, individual circumstances and genetics may impact this. In any event, the increase or decrease of ghrelin levels has important health consequences.   Wang's findings have important applications for environmental illness practioners considering that intestinal disease are often co-morbid with environmentally-induced conditions. Parkinson's disease is considered an environmental illness because it is exacerbated or believe to be caused by environmental factors. No doubt genetic factors play a part but there is mounting evidence that environmental toxicants may influence genetic disposition for the development of the disease. Understanding the relationship of ghrelin to Parkinson's disease (PD) is dependant on understanding that lower actions of ghrelin in the brain are associated with an increase in the loss of dopamine and lower dopamine levels in the brain are consistent with the etiology of PD. The author of this recent study remarks that further study will be needed to determine whether ghrelin can be used as a biomarker for PD or at least help to identify an increase in vulnerability. In any case, considering that LPS endotoxin may inhibit the production of ghrelin, normalizing ghrelin levels systemically may have the potential to have a positive impact on diseases where low/altered dopamine levels play a role such as PD and ADHD.

Dr. Lutter of UT Southwestern points out that "regulated" control of the production of this hormone is important for regulating behavior and mood and therefore, alterations in ghrelin may influence that condition of sickness syndrome. Lutter's findings show that ghrelin regulates mood, stress and energy levels and while blocking ghrelin production may provide a mechanism for weight control it can also increase feelings of depression and anxiety. In his experiments he found that ghrelin increases during stress and elevations can last for weeks after the stress event ends and animals which did not respond normally to ghrelin exhibited more depressive or anxious behaviors. The above findings may help to identify at least some of the causes of behavioral changes in this PD and other environmentally-induced illnesses. Another experiment demonstrated that endotoxemia in dogs resulted in an increase in leptin and ghrelin which correlated to an increase in NO, inflammatory mediators, cortisol and injury markers. Interestingly,  ghrelin increases occurred in cachetic mice with cancer with symptoms of changes of metabolism so the increase or decrease in ghrelin production may be dependant on production of cytokines such as TNF-a. Other studies show it attenuates other cytokine-induced anorexia and therefore, chnages in ghrelin production/secretion should be considered a factor in behavioral appetite changes associated with sickness and wasting syndrome (Hataya). Evidence shows that exogenous ghrelin inhibits Il-1 and TNF-a while augmenting the synthesis of Il-10 in endotoxin-stimulated immune cells. Waseem explains this modulatory action of ghrelin warrants further investigation. As we have explained in other blogs, Il-10 modulates sickness syndrome through HO-1 and therefore ghrelin has potential to indirectly modulate antioxidant mechanisms.

Because ghrelin has important roles in a number of animal behaviors, future research findings may provide important  insight and provide natural and pharmacological treatments for a number of diseases where ghrelin production is a factor.

The Balance Within: The Science Connecting Health and Emotions















The Psychoneuroimmunology of Chronic Disease: Exploring the Links Between Inflammation, Stress, and Illness












View original document and citations.